Christopher Liu's Stock Ratings

Leerink Partners Analyst

Christopher Liu is an analyst at Leerink Partners. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 12/15/2025

Updated: Dec 15, 2025

Overall Average Return

52.1%

Smart Score

74.1%

Overall Average Return Percentile

94th

Number of Ratings

9
Buy NowGet Alert
10/21/2025EXELBuy Now
Exelixis
$41.3216.17% → $48UpgradeMarket Perform → OutperformGet Alert
09/26/2025LYELBuy Now
Lyell Immunopharma
$34.34-41.77% → $20Initiates → BuyGet Alert
09/18/2025ADAGBuy Now
Adagene
$1.71426.32% → $9Initiates → BuyGet Alert
07/21/2025GNLXBuy Now
Genelux
$4.20138.27% → $10Initiates → BuyGet Alert
12/04/2024RLAYBuy Now
Relay Therapeutics
$8.17120.32%$19 → $18MaintainsOutperformGet Alert
11/05/2024IDYABuy Now
IDEAYA Biosciences
$33.73-19.95%$41 → $27DowngradeOutperform → Market PerformGet Alert
08/08/2023NUVLBuy Now
Nuvalent
$104.06-59.64% → $42Initiates → Market PerformGet Alert
08/08/2023IDYABuy Now
IDEAYA Biosciences
$33.73-2.16% → $33Initiates → OutperformGet Alert
08/08/2023EXELBuy Now
Exelixis
$41.32-56.44% → $18Initiates → Market PerformGet Alert